LabGenomics Co., Ltd. (084650.KQ)
KRW 2545.0
(-3.05%)
KRW 2545.0
(-3.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 73.12 Billion | 144.77 Billion | 202.4 Billion | 119.47 Billion | 33.17 Billion |
| Cost of Revenue | 40.73 Billion | 48 Billion | 76.99 Billion | 47.72 Billion | 20.22 Billion |
| Gross Profit | 32.39 Billion | 96.76 Billion | 125.41 Billion | 71.74 Billion | 12.94 Billion |
| Operating Expenses | 39.18 Billion | 30.56 Billion | 20.89 Billion | 16.84 Billion | 11.75 Billion |
| Selling, General and Administrative Expenses | 13.14 Billion | 9.34 Billion | 6.73 Billion | 5.89 Billion | 10.69 Billion |
| Research and Development Expenses | 2.81 Billion | 1.86 Billion | 556.87 Million | - | - |
| Other Expenses | 23.22 Billion | 326.92 Million | 394.8 Million | 169.23 Million | - |
| Cost and Expenses | 79.92 Billion | 78.56 Billion | 97.88 Billion | 64.57 Billion | 31.97 Billion |
| Operating Income | -2.87 Billion | 66.2 Billion | 104.51 Billion | 54.9 Billion | 1.08 Billion |
| Interest Expense | 4.96 Billion | 573.97 Million | 208.03 Million | 223.79 Million | 415.79 Million |
| Income Tax Expense | -1.83 Billion | 15.46 Billion | 25.27 Billion | 9.05 Billion | 112.86 Million |
| Earnings before Tax | -7.08 Billion | 63.39 Billion | 109.13 Billion | 51.82 Billion | 1.07 Billion |
| Net Income | -4.67 Billion | 48.39 Billion | 83.85 Billion | 42.76 Billion | 962.42 Million |
| Earnings Per Share Basic | -63.22 | 714.50 | 413.50 | 649.33 | 15.50 |
| Earnings Per Share Diluted | -63.22 | 714.50 | 413.50 | 649.33 | 15.50 |
| Weighted Average Shares Outstanding | 73.93 Million | 67.73 Million | 67.35 Million | 65.86 Million | 62.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.93 Million | 67.73 Million | 67.35 Million | 65.86 Million | 62.09 Million |
| Gross Margin | 0.44 | 0.67 | 0.62 | 0.60 | 0.39 |
| EBIT Margin | -0.01 | 0.50 | 0.55 | 0.48 | 0.15 |
| Profit Margin | -0.06 | 0.33 | 0.41 | 0.36 | 0.03 |
| EBITDA | -897.69 Million | 70.17 Billion | 107.85 Billion | 58.33 Billion | 4.88 Billion |
| Earnings Before Tax Margin | -0.04 | 0.46 | 0.52 | 0.46 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.23 Billion | 19.91 Billion | 22.01 Billion | 73.12 Billion | 21.17 Billion | 15.24 Billion |
| Cost of Revenue | 13.73 Billion | 13.51 Billion | 14.85 Billion | 40.73 Billion | 11.92 Billion | 7.18 Billion |
| Gross Profit | 8.49 Billion | 6.4 Billion | 7.16 Billion | 32.39 Billion | 9.25 Billion | 8.05 Billion |
| Operating Expenses | -11.39 Billion | -12.53 Billion | 17.03 Billion | 39.2 Billion | 9.14 Billion | 6.22 Billion |
| Selling, General and Administrative Expenses | 11.39 Billion | 12.53 Billion | 6.92 Billion | - | 2.62 Billion | 1.71 Billion |
| Research and Development Expenses | 563.96 Million | 810.68 Million | 1.19 Billion | - | 464.4 Million | 281.67 Million |
| Other Expenses | -22.79 Billion | -25.06 Billion | -1.18 Billion | -40.36 Million | 403.28 Million | -216.91 Million |
| Cost and Expenses | 13.73 Billion | 13.51 Billion | 31.88 Billion | 79.93 Billion | 21.06 Billion | 13.41 Billion |
| Operating Income | -2.9 Billion | -6.13 Billion | -9.85 Billion | -6.79 Billion | 110.4 Million | 1.83 Billion |
| Interest Expense | - | 1.38 Billion | 1.1 Billion | 4.96 Billion | 1.37 Billion | 2.1 Billion |
| Income Tax Expense | 748.76 Million | 961.21 Million | -2.69 Billion | -1.83 Billion | -1.05 Billion | 858.38 Million |
| Earnings before Tax | 957.21 Million | -8.13 Billion | -13.79 Billion | -7.08 Billion | -2.77 Billion | 4.11 Billion |
| Net Income | 226.22 Million | -9 Billion | -10.84 Billion | -4.67 Billion | -1.54 Billion | 3.36 Billion |
| Earnings Per Share Basic | 3.05 | -121.33 | -146.43 | - | -20.85 | 45.50 |
| Earnings Per Share Diluted | 3.05 | -121.33 | -146.22 | - | -20.85 | 45.50 |
| Weighted Average Shares Outstanding | 74.17 Million | 74.23 Million | 74.06 Million | 73.93 Million | 74.23 Million | 74.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.17 Million | 74.23 Million | 74.17 Million | 73.93 Million | 74.23 Million | 74.23 Million |
| Gross Margin | 0.38 | 0.32 | 0.33 | 0.44 | 0.44 | 0.53 |
| EBIT Margin | 0.38 | 0.32 | -0.37 | - | 0.11 | 0.26 |
| Profit Margin | 0.01 | -0.45 | -0.49 | -0.06 | -0.07 | 0.22 |
| EBITDA | 8.49 Billion | 6.4 Billion | -8.08 Billion | - | 2.4 Billion | 4.01 Billion |
| Earnings Before Tax Margin | -0.13 | -0.31 | -0.45 | -0.09 | 0.01 | 0.12 |
NC5A
300611
603179
HGLD
SKCIL
BEAUTY